Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Summit Therapeutics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 51 | 52 | +1 |
| Shares | 11.0M | 11.1M | +91.2K (+0.8%) |
| Value | $55.3M | $30.0M | −$25.3M (−45.7%) |
New holders (9)
Institutions that held Summit Therapeutics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 42,593 | $115.0K | 0.00% |
| Two Sigma Securities, LLC | 19,474 | $52.0K | 0.01% |
| Allspring Global Investments Holdings, LLC | 17,388 | $46.0K | 0.00% |
| Virtu Financial LLC | 13,649 | $37.0K | 0.00% |
| Jane Street Group, LLC | 12,143 | $33.0K | 0.00% |
| Vance Wealth, Inc. | 12,299 | $33.0K | 0.03% |
| National Bank of Canada | 3,241 | $9.00K | 0.00% |
| Adirondack Trust Co | 1,000 | $3.00K | 0.00% |
| Cutler Group LP | 100 | $0 | 0.00% |
Sold out (8)
Institutions that held Summit Therapeutics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| State of Wisconsin Investment Board | 29,100 | $146.0K |
| Arrowstreet Capital, Limited Partnership | 14,410 | $72.0K |
| Brewin Dolphin Ltd | 3,716 | $18.6K |
| Evoke Wealth, LLC | 3,200 | $16.0K |
| Penserra Capital Management LLC | 2,225 | $11.0K |
| The PNC Financial Services Group, Inc. | 2,000 | $10.0K |
| Quadrant Capital Group LLC | 847 | $4.00K |
| US Bancorp | 339 | $2.00K |